Announcement of the Open Market Consultation of the EU – Innovation Procurement project Instand-NGS4P

26 February 2021 – An Open Market Consultation of the H2020 Pre-Commercial Procurement of Instand-NGS4P will be held on 22-23 March 2021 regarding integrated and standardized Next Generation Sequencing workflows for personalised therapy.

In the Horizon 2020 project Instand-NGS4P, a buyer’s group of seven leading medical centres from five European countries uses Pre-Commercial Procurement to acquire innovative solutions for personalised therapy of cancer patients.  The project aims at improving Next Generation Sequencing workflows through their integration and standardisation. In preparation of this procurement, an Open Market Consultation will be held on the 22nd and 23rd of March 2021. Further information is available on the website of the project.

Seven hospitals from Austria, Italy, Germany, the Netherlands and France are working together in this project, inviting potentially interested bidders to participate in the open market consultation. The aim is to develop and test two fully integrated, standardized NGS workflows, from sample-pre-analytics to medical decision making, for routine diagnostics of common and rare cancers from adults and children.